04:37 AM EDT, 07/29/2026 (MT Newswires) -- CVC Capital Partners (CVC.AS) is exploring the sale of its retail pharmacy chain in China, Xi'an Yikang Pharmaceutical Co., Bloomberg reported Wednesday, citing people familiar with the matter. The Dutch private equity group is working with an unnamed adviser on the potential divestment, which could fetch $500 million to $600 million, according to the report. Discussions are ongoing and no final decisions have been taken. CVC did not immediately respond to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.